Meng-meng Han
State Key Laboratory Of Natural Medicines
Nanjing, 210009, China
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Engineered MSCs Break Endothelial-Myofibroblast Crosstalk in Pulmonary Fibrosis: Reconstructing the Vascular Niche.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 26, 2024
Surface-engineered mesenchymal stem cell for refractory asthma therapy: Reversing airway remodeling.
Surface-engineered mesenchymal stem cell for refractory asthma therapy: Reversing airway remodeling.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 25, 2024
Modulating Fibrotic Mechanical Microenvironment for Idiopathic Pulmonary Fibrosis Therapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: May 29, 2024
Reactive Oxygen Species-Responsive Nanoparticles Toward Extracellular Matrix Normalization for Pancreatic Fibrosis Regression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 02, 2024
Inhaled nanoparticles for treating idiopathic pulmonary fibrosis by inhibiting honeycomb cyst and alveoli interstitium remodeling.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 26, 2023
An Autologous Macrophage-Based Phenotypic Transformation-Collagen Degradation System Treating Advanced Liver Fibrosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 20, 2023
Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice.
Journal: Science advances
Published: July 19, 2023
Response letter to Sun et al, re: Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 21, 2022
Remodeling of imbalanced extracellular matrix homeostasis for reversal of pancreatic fibrosis.
Journal: Biomaterials
Published: August 08, 2022
Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy.
Pathological collagen targeting and penetrating liposomes for idiopathic pulmonary fibrosis therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 15, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026